2022-502440-12-00招募中2 期
Study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer
Centre Leon Berard, Centre Leon Berard, Centre Leon Berard3 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2023年8月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 48
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr GIRAUDET Anne-Laure
Scientific
Centre Leon Berard
研究点 (3)
Loading locations...
相似试验
招募中
2 期
Radiometabolic Therapy (RMT) with 177Lu PSMA in PSMA PET/CT positive advanced/metastatic tumours: a basket trial (LUBASKET)2024-519346-75-00Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.83
已完成
1 期
Radionuclide therapy using 177Lu-PSMA: a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)castrate-resistant prostate cancerACTRN12618001552279St Vincent's Hospital15
招募中
2 期
Phase I/II study assessing radioligand therapy (RLT) using 177Lu-PentixaTher for relapsed/refractory CXCR4+ acute leukemia.Acute Leukemia2022-501019-15-00Centre Hospitalier Universitaire De Nantes21
招募中
1 期
A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastomaGlioblastoma2024-520105-39-00Curasight A/S6
已完成
1 期
An early phase clinical trial evaluating the effectiveness of treatment of 177Lu-PSMA with idronoxil in men with castrate-resistant prostate cancer (LuPin Trial)ACTRN12618001073291St Vincent's Hospital Sydney56